The preliminary study and tentative animal study on the sintered PDLLA/TCP composites as bone fracture internal fixation.
Polyesters based on the lactic acid have been reported safety and biodegradation in the human beings for two decades. The greatest advantage of the material is its degradation only conducted by the hydrolysis, where the ester backbones are supposed to be unchained in the aqueous condition. The final degradable products are carbon dioxide and water which can be metabolized and digested in the physiological environment. The goal of this study was aimed to develop a composite sintered with poly-DL-lactide (PDLLA) and tricalcium phosphate (TCP) ceramic particles as orthopedic application. The TCP particles in a range of 30-60 wt% (with 5 wt% increment) were doped into the PDLLA matrix for the reinforcement, which were prepared by the melting and hot pressing techniques. The basic mechanical strength, biodegradable behavior, and biological response of the composites will be investigated in the study. Various techniques, such as pH meter, UV, FTIR, XRD ect., were used to examine and record the degradable process of the composites soaked in the saline for 1-16 weeks. The rabbit femur condyle fracture fixation test was used to evaluate the tissue compatibility and the effects of bone fracture fixation of the composites. The histological observation and x-ray photography were applied for investigating assistance. In the histological evaluation of rabbit femur condyle fracture fixation test, the surface of the composite with 50 wt% TCP addition was attached by the new generated bone without fibrous tissue around after 8 weeks implantation. The fracture bone was gradually healing and the composite always firmly and properly fixed on the fracture area during the implanted period, which provided a breeding environment for normal bone remodeling. The developed composite was thought to be an alternative material for orthopedic application in the future, especially in bone screw and bone plate.
Lin
F H
FH
Center for Biomedical Engineering, College of Medicine, National Taiwan University, Taipei.
Chen
T M
TM
Lee
C J
CJ
D000818:Animals; D001672:Biocompatible Materials; D001696:Biomechanical Phenomena; D002130:Calcium Phosphates; D002516:Ceramics; D005264:Femoral Fractures / Q000628:therapy; D005593:Fracture Fixation, Internal; D020007:Implants, Experimental; D008297:Male; D011091:Polyesters; D011817:Rabbits
D001672:Biocompatible Materials; D002130:Calcium Phosphates; D011091:Polyesters; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; C033616:poly(lactide); C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous